GOSS Gossamer Bio Inc
Company Analysis
Latest News
🟢 Gossamer Bio rises 6.3% — Biotech Sector Rallies on Positive Clinical Trial Data and Regulatory News
With Biotech (XBI) up 2.2%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is trading higher today, driven by a...
🔴 Gossamer Bio is trading 5% down with no clear catalyst
Gossamer Bio is trading at $9.12 (-5.01%), with no clear company-specific catalyst identified. - An October 26 report covered Chardan reiterating its Buy...
🟢 Gossamer Bio is trading 5% up today amid biotech sector strength
Gossamer Bio is trading at $10.08, up +5.22%, with biotech sector strength potentially supporting shares; no clearly reported company-specific announcement...
🔴 Gossamer Bio is trading 6.7% down in pre-market
Gossamer Bio is trading 6.7% lower at $8.94 pre-market, with no clearly reported company-specific announcement explaining the decline. - The stock closed at...
🟢 Gossamer Bio is trading 11% up today as biotech rises 2.10%
Gossamer Bio is trading at $9.39, up 11.34%, in a move aligned with broader biotech strength. - Biotech is up 2.10%, with industry sentiment supported by...
🟢 Gossamer Bio rises 5.2% — Biotech Sector Surges on M&A Activity and Positive Clinical Trial Data
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector is experiencing a significant...
🔴 Gossamer Bio is trading 5% down in pre-market alongside biotech ETF XBI's 3.65% pre-market drop
Gossamer Bio is trading at $8.00, down 5.09%, with biotech-sector weakness a possible factor. - Biotech ETF XBI was down 3.65% pre-market, while supplied...
🔴 Gossamer Bio is trading 5% down
Gossamer Bio is trading at $8.31, down -5.24%, with no company-specific announcement found to explain the October 19 decline. - A market headline feed showed...
🟢 Gossamer Bio is trading 5.45% up in pre-market with no clear company-specific catalyst
Gossamer Bio is trading at $9.39, up 5.45%, with no clear company-specific catalyst identified in the October 15 search. - The latest company announcement...
🔴 Gossamer Bio is trading 8.9% down in pre-market on October 15, 2026; broader-market link unconfirmed
Gossamer Bio is trading at $8.11, down 8.91%, in pre-market trading on October 15, 2026, with no company-specific catalyst identified. - In the prior session,...
🔴 Gossamer Bio is trading 5.6% down today amid 2.01% biotech ETF decline
Gossamer Bio is trading 5.6% lower at $9.21, with biotech sector weakness providing context for the decline. - The biotech sector ETF was down 2.01% during...
🟢 Gossamer Bio is trading 8% up on October 13, 2026 after Chardan initiated coverage with a Buy rating
Gossamer Bio is trading at $10.03, up 8.08%, after Chardan initiated coverage with a Buy rating and a $160 price target. - Chardan cites seralutinib’s FDA...
Chardan Slaps a $160 Target on a $10 Stock — Is Gossamer Bio a Hidden Gem or a Mirage Built on a Failed Trial?
Shares of Gossamer Bio jumped 11.5% in pre-market trading Monday after boutique investment bank Chardan initiated coverage with a Buy rating and an eye-popping...
🟢 Gossamer Bio is trading 11.52% up in pre-market after Chardan initiates coverage with a Buy rating
Gossamer Bio is trading 11.52% higher in pre-market at $10.35 after Chardan initiated coverage with a Buy rating and a $160 price target, citing seralutinib’s...
🔴 Gossamer Bio is trading 6.38% down; no clear catalyst identified
Gossamer Bio is trading 6.38% down at $9.25, with no clear company-specific catalyst identified. - Searches found no company-specific announcement or news on...
🔴 Gossamer Bio is trading 7.6% down on October 7, 2026, amid biotech-sector pressure
Gossamer Bio is trading at $9.96, down 7.61%, amid biotech-sector pressure. - No new company-specific announcement or direct catalyst was identified for the...
🔴 Gossamer Bio is trading 6.31% down in after-hours trading
Gossamer Bio is trading at $10.10, down -6.31%, with no clear company-specific catalyst identified for the October 6 after-hours decline. - Available search...
🟢 Gossamer Bio is trading 8% up in pre-market
Gossamer Bio is trading at $11.50, up 7.98% in pre-market, with no clear company-specific overnight catalyst identified. - Its latest prominent announcement...
🔴 Gossamer Bio is trading 6.1% down in pre-market
Gossamer Bio is trading 6.1% down at $10.00 in pre-market, with no clear company-specific overnight catalyst identified. - Shares declined 0.56% at the...
🟢 Gossamer Bio is trading 6.2% up in after-hours trading, with no clear company-specific catalyst identified
Gossamer Bio is trading $11.31, up 6.20%, with no clear company-specific announcement explaining the rise. - Regular-session close: $10.65; the provided price...